Real-world Evidence Solutions Market to be Worth $5.04 Billion by 2031

Personalized medicine is one of the emerging approaches to improving disease treatment and prevention, considering individuals’ variability in genes, environment, and lifestyle. However, the approach can be challenging, as it is difficult to design an effective treatment plan for a medically complex patient. A large amount of data needs to be analyzed, and providers may lack the resources to extract valuable information. The use of real-world evidence speeds up the transition to precision medicine.